A midst the rapidly evolving environments around us, one field that is observing breakthroughs in terms of technological capabilities is the life sciences and pharmaceutical sector. Disruptive technologies are ushering in an era and adding new dimensions to the existing capabilities of the products and services. One such example is the development of personalized medicines through advancements in genetics. With scientists inferring that certain medical conditions are inherited and based on the genetic coding of an individual, healthcare firms are progressing toward providing customized healthcare, based on the genetic/ DNA composition. To fuel this process, pharmaceutical and life sciences companies are resorting to advanced technologies like AI, machine learning, natural processing language, and most pertinently, automation.
Companies are revamping their infrastructure and focusing heavily on digitalization and cloud migration. Cloud migration also helps these firms to handle the massive volumes of data generated while maintaining top-notch security. In fact, life sciences enterprises are investing in automated and configurable data-quality solutions to respond to market changes actively. Besides, smart technology is also expanding the possibility of improving the assessment and treatment of patients using integrated medication. It is even enhancing the accuracy in treatment when compared to the usual procedures. Furthermore, organizations are embracing DevOps to achieve better quality code, faster recovery from application failures, and effectively monitor cost rationalization. Incorporating digital trends is thereby helping life sciences and pharmaceutical companies to stay relevant in the complex, decentralized, function-based healthcare environment. To add, in the wake of COVID-19, telepractice is also gaining momentum where licensed medical practitioners are catering to patients virtually and prescribing medicines online through a database website.
In order to assist organizations in the task of finding accomplished pharma and life sciences technology companies, we have compiled this issue of APAC CIO Outlook. In this edition, we have listed the top 10 pharma and life sciences technology companies 2020 to highlight the organizations that can escalate the chances of your growth. Equipped with innovative technological capabilities, these firms are set to transform the pharmaceutical and life sciences landscape. This edition also blends rich industry insights from subject-matter experts, CIOs, and CXOs, with real-life stories on how the solution providers have enhanced the capabilities of their clients. We hope this issue of APAC CIO Outlook helps you build the partnership you and your organization need, to foster a workspace driven by robust and efficient technology.
We present to you APAC CIO Outlook’s “Top 10 Pharma and Life Sciences Technology Companies - 2020.”
